Analysis of Comorbidity and Its Association with Disease Severity and Mortality Rate in Hospitalized COVID-19 Patients

Anthony Christanto, Aditya Sri Listyoko, Ngakan Putu Parsama Putra

Abstract


Background: Comorbidity is a major factor in determining the outcome of COVID-19. However, existing studies regarding comorbidities and the disease severity and mortality of COVID-19 are mostly based on studies in the whole community, and not on those admitted to hospitals. This study aims to determine the demographic profile of comorbidities among COVID-19 patients hospitalized in tertiary care referral hospitals and its association with disease severity and mortality.

Methods: We analyzed the data from 60 laboratory-confirmed patients in our hospital in Malang City, East Java, Indonesia from March 12th, 2020 to June 5th, 2020. We describe the demographic profile of the patients and perform statistical analysis to determine its relationship to disease severity and mortality.

Results: The majority of the study samples (66.7%) were categorized as having a severe disease. Thirty-seven samples (61.7%) had at least one comorbidity. The mortality rate among the study population is 30.0%, and 37.8% among those with comorbidities. The most prevalent comorbidity was hypertension (40.0%), followed by heart failure (35.0%) and diabetes (25.0%). There is a statistically significant relationship between the presence of comorbidities and disease severity and between disease severity and mortality (p<0.05). Diabetes was the only comorbidity with a significant relationship towards mortality in our study (p<0.05, OR 4.0 95% CI 1.16-13.74).

Conclusion: Comorbidities are associated with worse disease severity and death in hospitalized COVID-19 patients.

 


Full Text:

PDF

References


World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it [Internet]. World Health Organization. 2020 [cited 2020 Aug 13]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it

Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta bio-medica Atenei Parm. 2020;91(1):157–60.

World Health Organization. Update on the situation regarding the new coronavirus [Internet]. World Health Organization. 2020 [cited 2020 Jan 29]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?adgroupsurvey=%7Badgroupsurvey%7D&gclid=CjwKCAiA9aKQBhBREiwAyGP5lbJhBLYvL4aPp_BpK6NhpGHDlB0yNpbHl_X5KD1ySjS0RPfL2j3sGBoCQMsQAvD_BwE

Kementrian Kesehatan Republik Indonesia. Infeksi Emerging Kementerian Kesehatan RI [Internet]. Kementrian Kesehatan Republik Indonesia. 2020 [cited 2020 Jun 9]. Available from: https://infeksiemerging.kemkes.go.id/

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]. 2020;382(18):1708–20. Available from: https://doi.org/10.1056/NEJMoa2002032

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA [Internet]. 2020;323(11):1061–9. Available from: https://doi.org/10.1001/jama.2020.1585

World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet]. World Health Organization. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf

Guan W-J, Liang W-H, Zhao Y, Liang H-R, Chen Z-S, Li Y-M, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.

Kementerian Kesehatan Republik Indonesia. COVID-19 dalam angka per 3 juni 2020 [Internet]. Kementerian Kesehatan Republik Indonesia. 2020 [cited 2020 Jun 4]. Available from: https://www.kemkes.go.id/article/view/20060600001/covid-19-dalam-angka-per-6-juni-2020.html

Djaharuddin I, Munawwarah S, Nurulita A, Ilyas M, Tabri NA, Lihawa N. Comorbidities and mortality in COVID-19 patients. Gac Sanit. 2021;35 Suppl 2:S530–2.

Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ [Internet]. 2020 Mar 26;368:m1198. Available from: http://www.bmj.com/content/368/bmj.m1198.abstract

Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833–9.

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5.




DOI: https://doi.org/10.36497/jri.v42i1.278

Refbacks

  • There are currently no refbacks.




Copyright (c) 2022 Anthony Christanto, Aditya Sri Listyoko, Ngakan Putu Parsama Putra


INDEXING & PARTNER

SINTA Garuda Indonesian Scientific Journal Database (ISJD) Indonesia One Search (IOS) Crossref

ROAD-ISSN Dimensions Google Scholar 

 

Jurnal Respirologi Indonesia
pISSN: 0853-7704 - eISSN: 2620-3162
Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia
Phone: +62-21-2247-4845
Email: editor@jurnalrespirologi.org


An official publication by
the Indonesian Society of Respirology (ISR)

Creative Commons License
Creative Commons Attribution-NonCommercial 4.0 International License

Statcounter